Search details
1.
Management of uterine sarcomas and prognostic indicators: real world data from a single-institution.
BMC Cancer
; 18(1): 1247, 2018 Dec 13.
Article
in English
| MEDLINE | ID: mdl-30541504
2.
MMP-2 -1306C>T polymorphism in breast cancer: a case-control study in a South European population.
Mol Biol Rep
; 40(8): 5035-40, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23661021
3.
HTERT MNS16A polymorphism in breast cancer: a case-control study.
Mol Biol Rep
; 39(12): 10859-63, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-23065203
4.
HSP90, HSPA8, HIF-1 alpha and HSP70-2 polymorphisms in breast cancer: a case-control study.
Mol Biol Rep
; 39(12): 10873-9, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-23065205
5.
Ewing's sarcoma of the cervix: A case report of an unusual diagnosis in pregnancy treated with surgery, adjuvant VIDE and radiotherapy.
Oncol Lett
; 17(6): 5529-5535, 2019 Jun.
Article
in English
| MEDLINE | ID: mdl-31186774
6.
Evaluation of the prognostic and predictive value of HER-1/EGFR in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.
Oncology
; 72(5-6): 388-96, 2007.
Article
in English
| MEDLINE | ID: mdl-18187961
7.
Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor?
Onco Targets Ther
; 8: 1843-7, 2015.
Article
in English
| MEDLINE | ID: mdl-26229492
8.
Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG).
PLoS One
; 8(7): e70634, 2013.
Article
in English
| MEDLINE | ID: mdl-23923010
Results
1 -
8
de 8
1
Next >
>>